Household & Personal Products

How L’Oréal’s 20% stake in Galderma reshapes the skin‑care market.

PG shares hit a 52‑week low as analysts cut targets, yet institutions bet on P&G’s stable dividend and cost‑cut plans—what does this mean for investors?

Unilever’s spin‑off of Magnum ice‑cream sparks a brief share dip, yet investors see long‑term value from a leaner portfolio and clearer risk focus.

BNP Paribas lifts Kimberly‑Clark’s valuation by 6 % amid a 2026 acquisition preview, highlighting stronger EBITDA growth, lower debt‑to‑equity, and key regulatory risks that could reshape the deal’s value.

Discover how L’Oréal’s 20% stake in Galderma could unlock dermatology growth, synergies, and new markets while navigating regulatory and brand risks.

Procter & Gamble’s share drop on Dec‑7: CFO warns of a sharp October sales decline, sparking investor concerns about U.S. demand, margins, and competitive pressure—an in‑depth analysis of risks and growth opportunities.

Unilever spins off its ice‑cream unit, Magnum, to boost growth, yet shares drop to a 52‑week low as investors weigh the split’s impact on the company’s future.

PG’s brief share dip is a short‑term reaction to a mild U.S. sales slide, but its strong margins, cash flow, green‑product momentum and growing DTC channel keep its outlook robust for investors.

Unilever’s ice‑cream de‑merger sharpens focus, boosts investor clarity, and taps premium, health‑conscious trends for higher growth and competitive edge.

PG’s latest sales slump reveals a shift in US consumer price sensitivity and raises questions about its pricing strategy, market position and future growth plans.